Vancomycin-intermediate resistance in Staphylococcus aureus - ScienceDirect
Retrospective screening for heterogeneous vancomycin resistance in diverse Staphylococcus aureus clones disseminated in French h
Vancomycin-intermediate resistance in Staphylococcus aureus - ScienceDirect
![PDF] Emergence of vancomycin-intermediate Staphylococcus aureus in a Belgian hospital: microbiological and clinical features. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/306a583084d23ac2766f122cd384bf9952effebb/4-Figure2-1.png "PDF] Emergence of vancomycin-intermediate Staphylococcus aureus in a Belgian hospital: microbiological and clinical features. | Semantic Scholar")
PDF] Emergence of vancomycin-intermediate Staphylococcus aureus in a Belgian hospital: microbiological and clinical features. | Semantic Scholar
The First Vancomycin-Intermediate Staphylococcus aureus Strains Isolated from Patients in Thailand | Journal of Clinical Microbiology
Acknowledgements References Genetic analysis of 17 genes in Staphylococcus aureus with reduced susceptibility to vancomycin (VIS
Population analysis profile of VISA, hetero-VISA, and VSMRSA.... | Download Scientific Diagram
Le cauchemar des bactéries multirésistantes
Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: a systematic review and meta-analysis | Scientific Reports
Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: a systematic review and meta-analysis | Scientific Reports
Hetero-intermediate Staphylococcus aureus
Frontiers | IS256-Mediated Overexpression of the WalKR Two-Component System Regulon Contributes to Reduced Vancomycin Susceptibility in a Staphylococcus aureus Clinical Isolate
Impact of reduced vancomycin susceptibility on the therapeutic outcome of MRSA bloodstream infections | Annals of Clinical Microbiology and Antimicrobials | Full Text
Daptomycin and vancomycin heteroresistance revealed among CC5-SCCmecII MRSA clone and in vitro evaluation of treatment alternatives – CIBFar
Drug Class Review Monograph – GPI Class 02 – Cephalosporins
Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: a systematic review and meta-analysis | Scientific Reports
PDF) VISA, hetero-VISA and VRSA: the end of the vancomycin era?
xmlinkhub
14th March 2013 Susceptibility testing for Vancomycin in S. aureus : What do we do now? Robin A Howe Antimicrobial use in Primary Care. - ppt download
Investigation of Staphylococcus strains with heterogeneous resistance to glycopeptides in a Turkish university hospital
PAPs of three VISA isolates, one hetero-VISA isolate, and control... | Download Scientific Diagram
